46
Participants
Start Date
September 25, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
June 30, 2027
YK012
The treatments include 2 cycles of induction treatment, 3 cycles of consolidation treatment, and up to 5 cycles of maintenance treatment.
RECRUITING
Shengjing Hospital of China Medical University, Shenyang
RECRUITING
Affiliated Zhongshan Hospital of Dalian University, Dalian
RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
RECRUITING
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
RECRUITING
Henan Provincial People's Hospital, Zhengzhou
RECRUITING
Sun Yat-sen Memorial Hospital, Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
Guangdong Provincial People's Hospital, Guangzhou
RECRUITING
The Affiliated Hospital of Guizhou Medical University, Guiyang
RECRUITING
The Second Affiliated Hospital of Kunming Medical University, Kunming
Lead Sponsor
Excyte Biopharma Ltd
INDUSTRY